PALO ALTO, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CANCER COMMONS, founded in 2011, is a community nonprofit in the Health Care sector that reported $1.8M in total revenue in fiscal year 2024. Revenue surged 48% from the prior year, signaling strong growth momentum. Expenses of $1.7M left a modest 6% surplus.
CANCER COMMONS IS A NONPROFIT THAT PROVIDES PATIENTS, CAREGIVERS, AND TREATING PHYSICIANS WITH ACTIONABLE INFORMATION TO SUPPORT INFORMED TREATMENT DECISIONS, ALONG WITH DIRECT-TO-PATIENT NAVIGATION SERVICES FOR INDIVIDUALS WITH CANCER AND THEIR CAREGIVERS.
PATIENT NAVIGATION AND SUPPORT:CANCER COMMONS PROVIDED PERSONALIZED NAVIGATION AND EXPERT GUIDANCE TO APPROXIMATELY 1,200 NEW AND RETURNING CLIENTS DURING THE YEAR ENDED JUNE 30, 2025. MANY OF THESE...
PATIENT NAVIGATION AND SUPPORT:CANCER COMMONS PROVIDED PERSONALIZED NAVIGATION AND EXPERT GUIDANCE TO APPROXIMATELY 1,200 NEW AND RETURNING CLIENTS DURING THE YEAR ENDED JUNE 30, 2025. MANY OF THESE INDIVIDUALS FACED ADVANCED OR HARD-TO-TREAT CANCERS, INCLUDING BRAIN AND PANCREATIC CANCERS, WHERE TREATMENT DECISIONS ARE COMPLEX AND TIME-SENSITIVE.THE ORGANIZATION'S SERVICES HELP PATIENTS AND CAREGIVERS UNDERSTAND THEIR DIAGNOSIS, CLARIFY TREATMENT GOALS, AND EVALUATE TESTING, THERAPIES, AND CLINICAL TRIALS. EACH PATIENT IS PAIRED WITH A SCIENTIST WHO REVIEWS MEDICAL HISTORY, RESEARCHES ADDITIONAL TESTING, AND IDENTIFIES POTENTIAL TREATMENT PATHS AND TRIAL OPPORTUNITIES. THIS INDIVIDUALIZED SUPPORT EMPOWERS PATIENTS TO MAKE INFORMED DECISIONS AT CRITICAL MOMENTS IN THEIR CARE AND HELPS FAMILIES NAVIGATE AN OVERWHELMING AND RAPIDLY EVOLVING MEDICAL LANDSCAPE. DONOR SUPPORT ENABLES CANCER COMMONS TO PROVIDE THESE SERVICES AT NO COST TO PATIENTS.
LEARNING HEALTH SYSTEM DEVELOPMENT:CANCER COMMONS CONTINUED DEVELOPMENT ON THE LEARNING HEALTH SYSTEM (LHS), A TECHNOLOGY PLATFORM DESIGNED TO ACCELERATE AND IMPROVE TREATMENT DECISION-MAKING FOR...
LEARNING HEALTH SYSTEM DEVELOPMENT:CANCER COMMONS CONTINUED DEVELOPMENT ON THE LEARNING HEALTH SYSTEM (LHS), A TECHNOLOGY PLATFORM DESIGNED TO ACCELERATE AND IMPROVE TREATMENT DECISION-MAKING FOR PATIENTS WITH ADVANCED CANCERS. THE SYSTEM INTEGRATES REAL-WORLD PATIENT DATA AND AI-DRIVEN ANALYSIS TO HELP IDENTIFY PROMISING TREATMENT OPTIONS AND REFINE RECOMMENDATIONS OVER TIME. THIS WORK ADVANCES THE ORGANIZATION'S LONG-TERM VISION: A LEARNING HEALTH SYSTEM IN WHICH EACH PATIENT'S EXPERIENCE CONTRIBUTES TO KNOWLEDGE THAT BENEFITS THE NEXT. DONOR INVESTMENT IN THIS INITIATIVE HELPS BUILD A FUTURE WHERE PERSONALIZED, DATA-INFORMED CANCER CARE IS ACCESSIBLE TO ALL.
WEBSITE, MARKETING, AND COMMUNICATIONS:THE ORGANIZATION ADVANCED ITS WEBSITE, MARKETING, AND COMMUNICATIONS INITIATIVES TO SUPPORT AN UPDATED BRAND IDENTITY AND IMPROVE ACCESS TO PATIENT-FACING...
WEBSITE, MARKETING, AND COMMUNICATIONS:THE ORGANIZATION ADVANCED ITS WEBSITE, MARKETING, AND COMMUNICATIONS INITIATIVES TO SUPPORT AN UPDATED BRAND IDENTITY AND IMPROVE ACCESS TO PATIENT-FACING RESOURCES. DURING THE YEAR, CANCER COMMONS COMPLETED FOUNDATIONAL WORK, INCLUDING CONTENT DEVELOPMENT, DESIGN PLANNING, AND USER-EXPERIENCE IMPROVEMENTS THAT WILL ENABLE A FULL LAUNCH IN THE FOLLOWING FISCAL YEAR. THESE EFFORTS STRENGTHEN THE ORGANIZATION'S ABILITY TO REACH PATIENTS AND CAREGIVERS SEEKING TIMELY, TRUSTWORTHY GUIDANCE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,842,982 | $1,246,687 | +0.5% |
| Expenses | $1,726,483 | $1,171,436 | +0.5% |
| Net Income | $116,499 | $75,251 | +0.5% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JAY M TENENBAUM | FOUNDER AND CHAIRMAN | 20.00 |
Officer
Director
|
$0 | $0 | $0 |
| PAUL BILLINGS | VICE CHAIR AND ACTING CEO | 1.00 |
Officer
Director
|
$20,000 | $0 | $20,000 |
| LARRY MARTON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| VERN NORVIEL | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| GREG SIMON | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| BILL STASIOR | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DON MORRISON | BOARD MEMBER (FROM 2/27/25) | 1.00 |
Director
|
$0 | $0 | $0 |
| SHELLEY FRISBIE | CFO | 25.00 |
Officer
|
$58,500 | $0 | $58,500 |
| ADRIENNE NUGENT | CHIEF OPERATING OFFICER | 40.00 |
Key Emp
|
$170,000 | $180 | $170,180 |
| MASAKO YOKOTA | DIRECTOR, OFFICE OF THE CHAIRMAN | 40.00 |
Highest
|
$112,000 | $2,194 | $114,194 |
| SUNEETA MANDAVA | SENIOR CLINICAL ONCOLOGY SCIENTIST | 40.00 |
Highest
|
$148,000 | $18,819 | $166,819 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $1,842,982 | $1,726,483 | $668,478 | $116,499 |
| 2024 | No data | No data | No data | No data |
| 2023 | $1,164,344 | $1,582,845 | $408,611 | $-418,501 |
| 2022 | $1,655,358 | $1,636,180 | $832,926 | $19,178 |
| 2021 | $1,739,545 | $1,698,015 | $829,247 | $41,530 |
| 2020 | $2,104,386 | $1,929,886 | $883,100 | $174,500 |
| 2019 | $1,805,146 | $1,349,763 | $775,135 | $455,383 |
Compare CANCER COMMONS with other nonprofits in California and across the country.